Cancer Treatment in Sweden - Costs of Drugs, Inpatient and Outpatient Care from 1985 to 1996 and Cost Effectiveness of New Drugs

Author： Tennvall Gunnel Ragnarson   Karlsson Göran  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.37, Iss.5, 1998-10, pp. : 447-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New targets, drugs, and approaches for the treatment of cancer: An overview

By Kerbel R.S.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 145-147

Springer Publishing Company

Access to resources Recommend Favorite

New drugs in the treatment of recurrent or metastatic cervical cancer

By Savarese A.   Cognetti F.  

Critical Reviews in Oncology/Hematology, Vol. 48, Iss. 3, 2003-12 ,pp. : 323-327

Elsevier

Access to resources Recommend Favorite

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 79-101

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Biotechnological Drugs for Cancer Treatment

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

New Generation of Liposomal Drugs for Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 6, 2006-11 ,pp. : 537-552

Bentham Science Publishers

Access to resources Recommend Favorite